Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-09
DOI
10.1038/srep09694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation
- (2013) X. Shi et al. CLINICAL CANCER RESEARCH
- Bortezomib sensitivity of acute myeloid leukemia CD34+ cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1
- (2013) Matthieu Cornelis Johannes Bosman et al. EXPERIMENTAL HEMATOLOGY
- The Regulatory Roles of Apoptosis-Inducing Factor in the Formation and Regression Processes of Ocular Neovascularization
- (2012) Toshio Hisatomi et al. AMERICAN JOURNAL OF PATHOLOGY
- Evaluation of the Safety and Efficacy of Hydroxycitric Acid orGarcinia cambogiaExtracts in Humans
- (2012) Fabiola Márquez et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- In VitroandIn VivoToxicity ofGarciniaor Hydroxycitric Acid: A Review
- (2012) Li Oon Chuah et al. Evidence-based Complementary and Alternative Medicine
- Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo
- (2012) Xiaofen Li et al. Cell Reports
- Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition
- (2011) J. Hu et al. BLOOD
- A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma
- (2011) R. Bosch et al. BLOOD
- High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
- (2011) W. Warsch et al. BLOOD
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
- (2011) L S Steelman et al. LEUKEMIA
- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- Physiological levels of ATP negatively regulate proteasome function
- (2010) Hongbiao Huang et al. CELL RESEARCH
- Gambogic acid covalently modifies IκB kinase-β subunit to mediate suppression of lipopolysaccharide-induced activation of NF-κB in macrophages
- (2009) Umamaheshwari D. Palempalli et al. BIOCHEMICAL JOURNAL
- Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation
- (2009) X. Shi et al. CLINICAL CANCER RESEARCH
- Old target new approach: an alternate NF-κB activation pathway via translation inhibition
- (2009) Csaba F. László et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
- (2008) L S Steelman et al. LEUKEMIA
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
- (2008) Dayong Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K/Akt: getting it right matters
- (2008) T F Franke ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started